RxDoctor Payments Data

Sharika Seabrooks, NP

Adult Health · Hampton, GANPI 1952809501

Payments from drug & device makers

$1,867in general payments, 2019–2025

Across 36 payments — averaging $51.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Coloplast$189
  • Janssen Scientific Affairs, LLC$148
  • Baxter Healthcare$134
  • ABC Home Medical Supply, Inc.$87
  • Johnson & Johnson$74
  • plus $212 from 8 others

What the payments were for

  • Travel & lodging$64635%
  • Food & beverage$1,22065%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific9$1,024
Coloplast9$189
Janssen Scientific Affairs, LLC1$148
Baxter Healthcare2$134
ABC Home Medical Supply, Inc.4$87
Johnson & Johnson3$74
KARL Storz Endoscopy-america1$33
Convatec Inc.1$33
Sumitomo Pharma America, Inc.1$30
Teleflex LLC1$27
Civco Medical Instruments1$27
180 Medical, Inc.1$26
Tempus AI, Inc1$23
Hollister Incorporated1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,867 in reported general payments places this provider in the 75th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$8,274
Medicare patients
115
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron46$30,962
GemtesaVibegron31$20,457
Tamsulosin Hcl105$1,833
Oxybutynin Chloride ErOxybutynin Chloride27$507
Finasteride38$468
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$141
Doxazosin Mesylate12$124
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim34$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$30$20,45731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 577 adult health providers in Georgia.

Other adult health in Hampton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →